Authors Note: The structure of this letter is going to be a bit different from our usual, more narrative style at StayCurious Metabolism
Shiyanbola OO, Farris KB
Data in panel a,d,e,h,j and l were analyzed using 2-way ANOVA and with Bonferroni post-hoc comparison of individual time points
Up-regulation of anti-inflammatory factors, such as interleukin (IL)-10
Hippen: Given all of the challenges our patient population faces, we've already talked about in terms of access to physicians on a regular basis, access to these, in many cases, expensive medications, the need to have them on concomitant medications like RAS inhibition, how do we think through developing a different system of care delivery so that these medications get to the patients or the subclasses of patients who clearly benefit from them